Growing regulatory approvals, expanding biologics pipelines, and escalating financial investment in following-era peptide modalities carry on to produce 2025 a pivotal growth calendar year for your market.Ahead of diving into your specific reviews, here is an at-a-glance comparison on the leading peptide companies running while in the US industry.�